Ron is an intellectual property litigator and trial attorney with over 25 years of experience. He has represented clients in patent, trademark, false advertising, trade secret, and copyright cases across a broad spectrum of industries and technologies, and is widely respected as a pharmaceutical Hatch-Waxman litigator, primarily for generic drug companies. His Hatch-Waxman experience is extensive, covering dozens of patents, products, formulations and designs, and methods of use. He has also handled litigation involving email and mobile communications software patents, computer hardware, traditional publishing, financial software, globally recognized consumer products, and genetic science. In addition to his intellectual property litigation practice, Ron counsels startups and companies of all sizes regarding patent procurement and clearance, and domestic and international trademark prosecution and licensing. He has also represented a pro bono client in connection with a New York State post-conviction criminal proceeding and federal habeas corpus petition.
Ron has been involved in over 15 bench and jury trials and evidentiary hearings, and has been lead counsel or second chair in most of them. He has also argued before several U.S. Courts of Appeals and the New York State Appellate Division. Trial-tested courtroom skills underlay all parts of Ron’s practice, but he is also committed to working with clients to develop cost-effective strategies for results that make sound business sense — whether a client achieves those results inside or outside the courtroom.
A frequent writer and speaker on topics in the field of intellectual property, Ron also currently serves as an Advisory Board member of Bloomberg/BNA’s Life Sciences Law and Industry Report and an Amicus Committee member for the New York Intellectual Property Law Association. He is a graduate of the University of Michigan and Washington University in St. Louis School of Law.